Imagine a robot that can find your vein, draw blood, and apply a bandage all by itself. It uses smart cameras to see where the vein is, removing the need for a nurse to poke around. It's like a vending machine for blood tests that works just as well as a human professional.
Healthcare facilities face a chronic shortage of personnel to perform blood draws. Additionally, the venipuncture process remains manual and unstandardized, leading to potential medical errors and inconsistent patient experiences.
The VD-1, a fully-autonomous robotic device that handles the entire blood drawing process from vein detection to bandage application.
If you are a hospital lab dealing with a chronic shortage of healthcare personnel — this project developed the VD-1 robot that performs the whole venipuncture procedure without human intervention. It standardizes the process and has already been placed in a commercial setting at OLVG hospital.
If you are a lab chain dealing with high operational costs and staffing gaps — this project developed an autonomous device that handles everything from vein detection to bandaging. It maintains a first-time success rate comparable to human nurses.
If you are a distributor dealing with a lack of automated phlebotomy tools — this project developed a CE-marked device ready for sale within the EU. It is backed by nine filed patents and a Series A-1 funding round of €20M.
Based on available project data, specific pricing per unit or subscription costs are not disclosed, though the company has signed contracts for 13 devices.
Yes, the company has grown its team from 50 to approximately 100 people and is preparing the device for industrialization.
The technology is heavily protected with a total of nine patents filed on all essential parts of the device.
Yes, the VD-1 has obtained CE marking, allowing it to be sold within the European Union.
Based on available project data, the timeline for individual site installation is not specified, but the project period runs from 2023-06-01 to 2025-02-28.
The project is led by Vitestro BV, a Dutch SME. The consortium is lean, consisting of 2 partners, both of which are SMEs from the Netherlands. This 100% industry ratio indicates a strong commercial drive, further evidenced by their ability to raise €20M in Series A-1 funding and scale their team from 50 to 100 people.
Contact Vitestro BV in the Netherlands regarding the VD-1 commercial rollout.
Contact us to explore licensing or partnership opportunities with Vitestro BV.
